ALNAIR THERAPEUTICS
Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult-to-treat malignancies. It has created a first-of-its-kind drug delivery technology that uses the unique features of cancer metabolism to improve drug targeting and penetration directly into cancer cells, hence enhancing patient treatment outcomes.
ALNAIR THERAPEUTICS
Social Links:
Industry:
Biotechnology Oncology
Total Employee:
1+
Status:
Active
Total Funding:
1.76 M USD
Similar Organizations
ArcherDX
ArcherDX is a biotechnology firm specializing in cancer research.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Investors List
OCA Ventures
OCA Ventures investment in Pre Seed Round - Alnair Therapeutics
Gaingels
Gaingels investment in Pre Seed Round - Alnair Therapeutics
CJM Ventures
CJM Ventures investment in Pre Seed Round - Alnair Therapeutics
Portal Innovations
Portal Innovations investment in Pre Seed Round - Alnair Therapeutics
University of Chicago New Venture Challenge
University of Chicago New Venture Challenge investment in Grant - Alnair Therapeutics
George Shultz Innovation Fund
George Shultz Innovation Fund investment in Grant - Alnair Therapeutics
More informations about "Alnair Therapeutics"
Alnair Therapeutics 2025 Company Profile: Valuation, …
Alnair Therapeutics General Information Description. Operator of a precision oncology company designed to focus on new methods to treat difficult-to … See details»
Alnair Therapeutics - LinkedIn
Alnair is a preclinical stage, platform precision oncology company focused on new methods to treat difficult-to-treat cancers. We developed a first-in-class drug delivery technology that leverages ... See details»
Alnair Therapeutics Follows Polsky Path to String of …
Jul 5, 2023 Momentum continues to build for Alnair Therapeutics, an oncology startup focused on developing a platform to better deliver drugs to hard-to-treat cancers. In June – the same month that the company won the 27th Annual … See details»
Alnair Therapeutics Inc · University of Chicago
ALNAIR THERAPEUTICS INC is an entity in Chicago, Illinois registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The entity was registered on … See details»
Alnair Therapeutics Information - RocketReach
View Top Employees from Alnair Therapeutics Alnair is a preclinical stage, platform precision oncology company focused on new methods to treat difficult-to-treat cancers. We developed a … See details»
Alnair Therapeutics - Products, Competitors, Financials, Employees ...
Alnair Therapeutics's latest funding round is Pre-Seed. How much did Alnair Therapeutics raise? Alnair Therapeutics raised a total of $1.77M. Who are the investors of Alnair Therapeutics? … See details»
Alnair Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Alnair Therapeutics Inc. of Chicago, IL. Get the latest business insights from Dun & Bradstreet. See details»
Alnair Therapeutics - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 100 Translational Medicine associated with Alnair Therapeutics. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full … See details»
Alnair Therapeutics - Crunchbase Company Profile & Funding
Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult-to-treat malignancies. It has created a first-of-its-kind drug … See details»
Alnair Therapeutics - Company Profile - Tracxn
Nov 5, 2024 Alnair Therapeutics ranks 1,863rd among 50723 active competitors. 308 of its competitors are funded while 795 have exited. Overall, Alnair Therapeutics and its competitors … See details»
Alnair Therapeutics Awarded $175,000 From George …
Jan 30, 2023 Alnair Therapeutics joins Riptide Therapeutics as the Fall 2022 GSIF cohort winners. Both will receive a $175,000 investment from the Fund. Both will receive a $175,000 investment from the Fund. During the GSIF … See details»
Alnair Therapeutics - 2025 Funding Rounds & List of Investors - Tracxn
Apr 25, 2025 Alnair Therapeutics has raised a total funding of $1M over 1 round from 3 investors. Investors include OCA Ventures, Portal Innovations and 1 other. Their latest funding round was of … See details»
MBA Ventures: More Than $1.75M In Prize Money Awarded At 2 …
Jun 11, 2023 From Chicago: Alnair Therapeutics, a startup developing a platform technology to improve the delivery of drugs to difficult-to-treat cancers, has won first place in the 27th Annual … See details»
Alnair Therapeutics - Funding, Financials, Valuation & Investors
Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult. New. Resources. ... How much funding has this … See details»
Alnair Therapeutics - Updates, News, Events, Signals & Triggers
Jun 30, 2023 Organization. Alnair Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Recent News & Activity. Edit Recent News & … See details»
Alnair Therapeutics on LinkedIn: Alnair Therapeutics lands ...
Alnair Therapeutics is excited to announce the closing of our $1M+ oversubscribed Pre-Seed funding round to support the preclinical development of our novel oncology platform. See details»
Alnair Therapeutics - Polsky Center for Entrepreneurship and …
11th Annual Booth-Kellogg ETA Conference Hosts Record Number of Attendees See details»
Oncology Startup Takes Home First Place at 2023 NVC as Judges …
Jun 2, 2023 Alnair Therapeutics, a startup developing a platform technology to improve the delivery of drugs to difficult-to-treat cancers, has won first place in the 27th Annual Edward L. Kaplan, ’71, … See details»
2 Startups Awarded $175,000 Each to Further Develop Cancer …
Jan 30, 2023 Alnair Therapeutics and Riptide Therapeutics have been awarded investments from the George Shultz Innovation Fund to further develop their cancer treatment technologies. Both … See details»
Class of 2025 Student Spotlights | University of Chicago Law School
9 hours ago Pacheco was matched with UChicago Professor Xiaoyang Wu, whose cancer research created the basis for breakthrough cancer treatment technology at a startup called Alnair … See details»